Care Disengagement Prevention for People Living with HIV in Indonesia
Official title: Care Disengagement Prevention in Treatment Naive Indonesians Living With HIV
Run by University of California, Los Angeles · NCT07706634 · Data updated 2026-11-12
This intervention tests a stigma-reduction approach to help people living with HIV in Indonesia stay connected with HIV care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Depok, West Java) |
| Status | Recruiting |
| Started | February 11, 2026 |
| Main results expected | January 31, 2028 |
| Study ends | January 31, 2028 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07706634 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults living with HIV in Indonesia who can provide informed consent and attend study visits.
✕Probably not a fit
Individuals who cannot participate fully due to cognitive impairment or severe comorbidities may not experience benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines how stigma and cultural factors affect engagement in HIV care among people living with HIV in Indonesia. It implements an evidence-based stigma-reduction intervention aimed at improving retention in care and, ultimately, health outcomes. The study leverages collaboration between UCLA, NIH partners, and Indonesian institutions to adapt and apply strategies in a real-world setting. Findings may inform efforts to reduce stigma and improve care engagement in diverse populations. The focus on Indonesia provides insights that could inform broader stigma-reduction efforts, including those relevant to the U.S. Ending the HIV Epidemic initiative.
Why it matters
Potential benefit: If successful, participants may experience better engagement with HIV care and improved health outcomes.
How similar studies have gone: Prior stigma-reduction approaches have shown promise in improving care engagement in other settings, but context-specific evidence in Indonesia is needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Living with HIV * Able to give informed consent * Able to attend study visits Exclusion Criteria: * Condition that prevents full participation in the study such as neurological disease, major depression or cardiovascular disease * Unable to communicate
Where it's running
-
University of Indonesia Hospital
Depok, West Java, Indonesia Recruiting
Study contacts
- Study coordinator: Wei-Ti Chen, RN, CNM, Ph.D., FAAN
- Email: wchen@sonnet.ucla.edu
- Phone: 310-206-8539
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AWARE.HIV Europe: supporting hospital teams to find undiagnosed HIV across Europe
This project will test whether putting dedicated HIV teams into hospitals increases HIV testing for people who come in with conditions that could suggest HIV across ten European countries.
-
Reducing Racism and Discrimination in HIV Care
This study is trying to see if training programs can help reduce racism and discrimination in HIV care for BIPOC patients and healthcare workers in the Southern and Eastern U.S.
-
Exploring how forgiveness affects quality of life in people living with HIV
This study looks at how forgiveness might improve the quality of life for people living with HIV by reducing stress and resentment.
-
Stigma Healing Inventory: See if a global program can reduce stigma for kids with cancer and their caregivers
This study tests a stigma-reduction program for children with cancer and their caregivers to see if it lowers stigma across different cultures.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.